Home » Tags

BPL-1357

BPL-1357

Jeffrey Taubenberger, Acting NIAID Director, with laboratory research materials
BPL-1357 BPL-24910 Intranasal-Vaccine

Intranasal Vaccine Brain Risk: The 2026 BPL-1357 Policy Playing Out

The scientific case for pausing NIAID's intranasal whole-virus platforms: direct olfactory-nerve access to the brain, full structural proteins …

Vaccine Safety
Read More →

About Measslainte

Independent research by Thomas Emmett III, exploring natural health protocols, cellular detox, and chronic recovery strategies. Evidence-based, no hype.

Disclaimer: This content is for educational purposes only and not medical advice. Claims are based on emerging research. Consult a healthcare professional before making changes to your diet or supplement regimen, especially if you have underlying health conditions or are taking medications.

Follow @MeasslainteIRL on X

Methodology & Transparency: Evidence grading, sourcing standard, and correction policy. Methodology page. Self-funded. No industry ties.